BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6250792)

  • 1. Uremia decreases nuclear 3,5,3'-triiodothyronine receptors in rats.
    Thompson P; Burman KD; Lukes YG; McNeil JS; Jackson BD; Latham KR; Wartofsky L
    Endocrinology; 1980 Oct; 107(4):1081-4. PubMed ID: 6250792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of postoperative factors on serum thyroid hormones and rat liver nuclear 3,5,3'-triiodothyronine receptor concentrations in surgical models of uremia and regenerating liver.
    Barsano CP; Burke SF; Quintana M; Quintanilla A; Iqbal Z; Munoz E
    Endocrinology; 1987 Apr; 120(4):1354-60. PubMed ID: 3830053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced triiodothyronine content in liver but not pituitary of the uremic rat model: demonstration of changes compatible with thyroid hormone deficiency in liver only.
    Lim VS; Passo C; Murata Y; Ferrari E; Nakamura H; Refetoff S
    Endocrinology; 1984 Jan; 114(1):280-6. PubMed ID: 6317348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solubilized nuclear thyroid hormone receptors in circulating human mononuclear cells.
    Burman KD; Latham KR; Djuh YY; Smallridge RC; Tseng YC; Lukes YG; Maunder R; Wartofsky L
    J Clin Endocrinol Metab; 1980 Jul; 51(1):106-16. PubMed ID: 6247359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes decreases liver and kidney nuclear 3,5,3'-triiodothyronine receptors in rats.
    Jolin T
    Endocrinology; 1987 May; 120(5):2144-51. PubMed ID: 3552632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific nuclear binding sites of triiodothyronine and reverse triiodothyronine in rat and pork liver: similarities and discrepancies.
    Wiersinga WM; Chopra IJ; Solomon DH
    Endocrinology; 1982 Jun; 110(6):2052-8. PubMed ID: 7075548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon administration decreases hepatic nuclear triiodothyronine binding capacity.
    Dillmann WH; Bonner RA; Oppenheimer JH
    Endocrinology; 1978 May; 102(5):1633-6. PubMed ID: 217631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear thyroxine and triiodothyronine binding in mononuclear cells in dependence of age.
    Kvetny J
    Horm Metab Res; 1985 Jan; 17(1):35-8. PubMed ID: 2981761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in hepatic triiodothyronine binding capacity induced by fasting.
    Burman KD; Lukes Y; Wright FD; Wartofsky L
    Endocrinology; 1977 Oct; 101(4):1331-4. PubMed ID: 198201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contribution of local tissue thyroxine monodeiodination to the nuclear 3,5,3'-triiodothyronine in pituitary, liver, and kidney of euthyroid rats.
    Silva JE; Dick TE; Larsen PR
    Endocrinology; 1978 Oct; 103(4):1196-207. PubMed ID: 217671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro 3,5,3'-triiodothyronine binding to rat cerebrocortical neuronal and glial nuclei suggests the presence of binding sites unavailable in vivo.
    Kolodny JM; Larsen PR; Silva JE
    Endocrinology; 1985 May; 116(5):2019-28. PubMed ID: 2985367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear triiodothyronine receptor in differentiating preadipocytes cloned from obese and lean mice.
    Anselmet A; Gharbi-Chihi J; Torresani J
    Endocrinology; 1984 Feb; 114(2):450-6. PubMed ID: 6317354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of hepatic mitochondrial alpha-glycerophosphate dehydrogenase and malic enzyme to 3,5,3'-triiodothyronine in streptozotocin-diabetic rats.
    Jolin T
    Endocrinology; 1988 Jul; 123(1):248-57. PubMed ID: 3383774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid hormone action: in vitro characterization of solubilized nuclear receptors from rat liver and cultured GH1 cells.
    Samuels HH; Tsai JS; Casanova J; Stanley F
    J Clin Invest; 1974 Oct; 54(4):853-65. PubMed ID: 4372251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes, hypophysectomy, or thyroidectomy reduces nuclear L-triiodothyronine-binding capacity of rat lung.
    Das DK; Ganguly M
    Endocrinology; 1981 Jul; 109(1):296-300. PubMed ID: 6263588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5,5'-Diphenylhydantoin decreases specific 3,5,3'-triiodothyronine (T3) binding by rat hepatic nuclear T3 receptors.
    Mann DN; Surks MI
    Endocrinology; 1983 May; 112(5):1723-31. PubMed ID: 6299706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased hepatic nuclear L-triiodothyronine receptors in rats and mice bearing transplantable neoplasms.
    Surks MI; Grajower MM; Tai M; DeFesi CR
    Endocrinology; 1978 Dec; 103(6):2234-9. PubMed ID: 218807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding parameters of rat liver nuclear receptors for T3 after partial hepatectomy or bilateral adrenalectomy and serum T4 and T3 levels.
    Brtko J; Knopp J
    Endocrinol Exp; 1988 Dec; 22(4):211-20. PubMed ID: 3243202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The specific binding of the thyroid hormones to matrix isolated from rat liver nuclei.
    Wilson BD; Albrecht CF; Wium CA
    S Afr Med J; 1982 Jan; 61(2):44-9. PubMed ID: 6277016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation of serum triiodothyronine concentration and hepatic nuclear triiodothyronine-binding capacity in streptozotocin-induced diabetic rats.
    Las MS; Surks MI
    Endocrinology; 1981 Oct; 109(4):1259-63. PubMed ID: 6269840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.